Redcare Pharmacy (DE:RDC)

XETRA:RDC

RDC

Redcare Pharmacy

RESEARCH TOOLSreports

Redcare Pharmacy (RDC) Price & Analysis

68 Followers

RDC Stock Chart & Stats

€37.22

€4.70(3.90%)

At close: Jan 09 4:00 PM EST

€37.22

€4.70(3.90%)

Day’s Range― - ―

52-Week Range€30.20 - €136.50

Previous CloseN/A

Volume73.26K

Average Volume (3M)132.76K

Market Cap

€765.93M

Enterprise Value€1.08B

Total Cash (Recent Filing)€203.50M

Total Debt (Recent Filing)€415.60M

Price to Earnings (P/E)―

Beta1.45

Next Earnings

May 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.44

Shares Outstanding20,578,390

10 Day Avg. Volume128,637

30 Day Avg. Volume132,758

Financial Highlights & Ratios

PEG Ratio1.97

Price to Book (P/B)2.85

Price to Sales (P/S)0.45

P/FCF Ratio-23.25

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€97.93

Price Target Upside163.11% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering7

EPS Forecast (FY)-0.32

Revenue Forecast (FY)€3.35B

Bulls Say, Bears Say

Bulls Say

Competitive PositioningMeeting sales targets despite challenging market conditions signals improving competitive positioning and potential share gains in key markets.

Prescription Medicines GrowthAccelerated prescription medicines sales in Germany enabled the firm to meet its sales target, indicating strong demand in the core prescription segment.

Valuation Re-ratingRobust overall sales growth supports the case for the stock to be reassessed at a higher valuation by market analysts.

Bears Say

Consumer/non-prescription SegmentWeaker-than-expected performance in the non-prescription segment, even amid a strong flu season, raises concerns about consumer demand and revenue diversification.

Management Guidance CredibilityManagement's medium-term revenue and margin targets are weaker than market expectations and sit below consensus, undermining confidence in the company's outlook.

Profitability And MarginsRapid prescription sales growth occurred at the expense of profitability, with operating margins slipping to the low end of guidance and creating pressure on earnings expectations.

Redcare Pharmacy News

Buy Rating Maintained as Strong Prescription Growth and Long-Term Margin Ambition Outweigh Near-Term Profitability Pressure

Redcare Pharmacy, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Martin Comtesse from...

1M ago

0RJT Upcoming Earnings Report: What to Expect?

Redcare Pharmacy (0RJT) is scheduled to report 4th quarter earnings on 03/04/2026. Regarding Q4 estimates, Wall Street analysts...

1M ago

Positive Financial Performance and Growth Prospects Justify Buy Rating for Redcare Pharmacy

Jefferies analyst Martin Comtesse maintained a Buy rating on Redcare Pharmacy today and set a price target of...

5M ago

Redcare Pharmacy’s Rebound: Analyst Recommends Buy Amidst Sales Recovery and Strong Future Outlook

Martin Comtesse, an analyst from Jefferies, maintained the Buy rating on Redcare Pharmacy. The associated price target remains...

6M ago

Optimistic Buy Rating for Redcare Pharmacy Driven by Market Expansion and Strategic Digital Transformation

Redcare Pharmacy, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Martin Comtesse from...

7M ago

Redcare Pharmacy: Strong Financial Performance and Positive Outlook Justify Buy Rating

Jefferies analyst Martin Comtesse maintained a Buy rating on Redcare Pharmacy today and set a price target of...

8M ago

0RJT Earnings this Week: How Will it Perform?

Redcare Pharmacy (0RJT) is scheduled to report 2nd quarter earnings on 07/29/2025. Regarding Q2 estimates, Wall Street analysts...

8M ago

Redcare Pharmacy: Stable Performance and Growth Potential Amidst Temporary Challenges

Analyst Martin Comtesse from Jefferies maintained a Buy rating on Redcare Pharmacy and keeping the price target at...

9M ago

0RJT Upcoming Earnings Report: What to Expect?

Redcare Pharmacy (0RJT) is scheduled to report 1st quarter earnings on 05/06/2025. Regarding Q1 estimates, Wall Street analysts...

11M ago

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Stifel Nicolaus analyst Yannik Siering maintained a Buy rating on Redcare Pharmacy (0RJT – Research Report) today and...

1y ago

RDC FAQ

What was Redcare Pharmacy’s price range in the past 12 months?

Redcare Pharmacy lowest stock price was €30.20 and its highest was €136.50 in the past 12 months.

What is Redcare Pharmacy’s market cap?

Redcare Pharmacy’s market cap is €765.93M.

When is Redcare Pharmacy’s upcoming earnings report date?

Redcare Pharmacy’s upcoming earnings report date is May 06, 2026 which is in 29 days.

How were Redcare Pharmacy’s earnings last quarter?

Redcare Pharmacy released its earnings results on Mar 04, 2026. The company reported -€1.44 earnings per share for the quarter, missing the consensus estimate of -€0.504 by -€0.936.

Is Redcare Pharmacy overvalued?

According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Redcare Pharmacy pay dividends?

Redcare Pharmacy does not currently pay dividends.

What is Redcare Pharmacy’s EPS estimate?

Redcare Pharmacy’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Redcare Pharmacy have?

Redcare Pharmacy has 20,578,390 shares outstanding.

What happened to Redcare Pharmacy’s price movement after its last earnings report?

Redcare Pharmacy reported an EPS of -€1.44 in its last earnings report, missing expectations of -€0.504. Following the earnings report the stock price went down -21.008%.

Which hedge fund is a major shareholder of Redcare Pharmacy?

Currently, no hedge funds are holding shares in DE:RDC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Redcare Pharmacy Stock Smart Score

Neutral

Fundamentals

Return on Equity

-7.76%

Trailing 12-Months

Asset Growth

21.28%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Redcare Pharmacy

Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Redcare Pharmacy (RDC) Earnings & Revenues

Historic Earnings Reports

RDC Stock 12 Month Forecast

Average Price Target

€97.93

▲(163.11% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"36":"€36","151":"€151","64.75":"€64.8","93.5":"€93.5","122.25":"€122.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€150.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.93,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€97.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[36,64.75,93.5,122.25,151],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.14,45.821538461538466,54.503076923076925,63.184615384615384,71.86615384615385,80.54769230769232,89.22923076923078,97.91076923076923,106.5923076923077,115.27384615384616,123.95538461538463,132.6369230769231,141.31846153846155,{"y":150,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.14,41.816153846153846,46.49230769230769,51.16846153846154,55.84461538461539,60.52076923076923,65.19692307692308,69.87307692307692,74.54923076923077,79.22538461538463,83.90153846153846,88.57769230769232,93.25384615384615,{"y":97.93,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.14,37.36,37.58,37.8,38.02,38.24,38.46,38.68,38.9,39.12,39.34,39.56,39.78,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":122.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.05,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.35,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.14,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >